ISU Abxis Co. Ltd (086890) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, ISU Abxis Co. Ltd (086890) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.56 Billion ≈ $7.15 Million USD) by net assets (₩120.39 Billion ≈ $81.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of ISU Abxis Co. Ltd for the company's overall valuation and market capitalisation.

ISU Abxis Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how ISU Abxis Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ISU Abxis Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ISU Abxis Co. Ltd ranked by their cash flow conversion efficiency. Explore 086890 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
MGI Digital PA:ALMDG	0.015x
Ta Yih Industrial Co Ltd TW:1521	-0.021x
Meiwu Technology Co Ltd NASDAQ:WNW	0.047x
China Tianrui Group Cement Company Limited F:T18	0.021x
ENTERA BIO IS-0000769 F:5DT	-0.140x
Newbridge Acquisition Limited Class A Ordinary Share NASDAQ:NBRG	0.115x
Apollo Minerals Ltd AU:AON	-0.137x
Westlin Corporation NASDAQ:WSTN	-0.003x

Annual Cash Flow Conversion Efficiency for ISU Abxis Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of ISU Abxis Co. Ltd from 2014 to 2024. View ISU Abxis Co. Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩100.86 Billion ≈ $68.35 Million	₩2.54 Billion ≈ $1.72 Million	0.025x	+172.20%
2023-12-31	₩77.19 Billion ≈ $52.31 Million	₩-2.69 Billion ≈ $-1.82 Million	-0.035x	-459.13%
2022-12-31	₩64.41 Billion ≈ $43.65 Million	₩-401.66 Million ≈ $-272.20K	-0.006x	+92.31%
2021-12-31	₩71.95 Billion ≈ $48.76 Million	₩-5.84 Billion ≈ $-3.96 Million	-0.081x	+58.72%
2020-12-31	₩43.57 Billion ≈ $29.53 Million	₩-8.56 Billion ≈ $-5.80 Million	-0.197x	+17.50%
2019-12-31	₩55.18 Billion ≈ $37.40 Million	₩-13.15 Billion ≈ $-8.91 Million	-0.238x	-6.37%
2018-12-31	₩59.73 Billion ≈ $40.48 Million	₩-13.38 Billion ≈ $-9.07 Million	-0.224x	-101.74%
2017-12-31	₩62.05 Billion ≈ $42.05 Million	₩-6.89 Billion ≈ $-4.67 Million	-0.111x	-86.96%
2016-12-31	₩45.58 Billion ≈ $30.89 Million	₩-2.71 Billion ≈ $-1.83 Million	-0.059x	+28.68%
2015-12-31	₩46.59 Billion ≈ $31.57 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.083x	+87.39%
2014-12-31	₩17.41 Billion ≈ $11.80 Million	₩-11.49 Billion ≈ $-7.79 Million	-0.660x	--

About ISU Abxis Co. Ltd

KQ:086890 Korea Pharmaceuticals

Market Cap

$61.53 Million

₩90.79 Billion KRW

Market Cap Rank

#21218 Global

#1221 in Korea

Share Price

₩3410.00

Change (1 day)

+0.44%

52-Week Range

₩2975.00 - ₩6240.00

All Time High

₩22450.00